VU University Medical Center Amsterdam Is First Continental European SOMAscan® Assay Site

VU University Medical Center Amsterdam Is First Continental European SOMAscan® Assay Site


SomaLogic, Inc., and VU University Medical Center Amsterdam (VUmc), announced today that the SOMAscan assay, a breakthrough proteomics platform, will be deployed at VUmc for its scientists’ use in multiple different biomedical research projects. The assay will be performed under the direction of Dr. Charlotte E. Teunissen.

“We are delighted that VUmc will be the first institution in mainland Europe to offer its researchers access to this cutting-edge proteomics platform,” said Dr. Teunissen. “I believe that many critical new insights into biology and disease will come from our deployment of the SOMAscan assay.”

Compared to other current proteomic technologies, SomaLogic’s platform gives researchers unprecedented power for protein biomarker discovery, diagnostics development and pharmaceutical discovery and development. SOMAmer® reagents, which are at the center of SomaLogic’s proteomics platform, are a new class of superior protein-binding reagents that combine the best properties of both monoclonal antibodies and traditional aptamers. The SOMAscan assay, which incorporates 1,310 different SOMAmer reagents, efficiently, accurately and rapidly measures proteins across a wide range of concentrations in small volumes of multiple biological sample types, accelerating the discovery of biomarkers across a wide range of diseases and conditions.

“We are excited to partner with VUmc to expand access to our technology in Europe,” said Byron Hewett, Chief Executive Officer of SomaLogic. “Under the direction of Dr. Teunissen, we believe that the SOMAscan assay will accelerate many new discoveries and their applications in biomedical research at VUmc and beyond.”

VUmc is the first major research center on the European mainland to deploy the SOMAscan platform onsite. SomaLogic is continuing to expand access to the platform through additional placements to be announced over the next several months.

For more information about VUmc, please visit